ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GSK Gsk Plc

1,348.00
-1.50 (-0.11%)
Last Updated: 15:39:23
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.50 -0.11% 1,348.00 1,347.50 1,348.00 1,356.50 1,344.00 1,345.00 2,832,567 15:39:23
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1889 11.36 55.94B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,349.50p. Over the last year, Gsk shares have traded in a share price range of 1,282.50p to 1,820.00p.

Gsk currently has 4,145,119,334 shares in issue. The market capitalisation of Gsk is £55.94 billion. Gsk has a price to earnings ratio (PE ratio) of 11.36.

Gsk Share Discussion Threads

Showing 34176 to 34195 of 34200 messages
Chat Pages: 1368  1367  1366  1365  1364  1363  1362  1361  1360  1359  1358  1357  Older
DateSubjectAuthorDiscuss
10/1/2025
14:56
hTTps://www.biospace.com/business/gsk-backed-ouro-launches-with-115m-to-reset-the-immune-system
dplewis1
10/1/2025
13:51
TM - that is a good move.
alphorn
09/1/2025
22:37
Do you think GSK is a safe bet?
arlington chetwynd talbott
09/1/2025
12:14
IN @ 1358.8 .... ;o)
tradermichael
09/1/2025
12:01
US market closed today, so not expecting the usual 2.30pm wipe out here.
tradermichael
09/1/2025
11:56
Does this have the defensive characteristics it once had, or does it, after spinning out Haleon, have a centre of gravity that is just too close to the cutting edge of pharma?
arlington chetwynd talbott
09/1/2025
11:36
The U.S. Food and Drug Administration's request for a label warning about Guillain-Barre syndrome risk on GSK's respiratory syncytial virus shot Arexvy could negatively impact vaccine sales, Bryan Garnier Research analysts say in a note. While a causal link between vaccination and GBS-- a rapid-onset muscle weakness caused by the immune system-- hasn't been proven, seven GBS cases per million Arexvy doses were observed, according to the FDA. "We believe the observed GBS incidence very close to natural GBS incidence in the non-vaccinated population," the analysts say. Arexvy sales already declined double-digit in 2H of 2024, following the narrowed recommendation to a smaller age range and more at-risk patients, the analysts say. Shares fall 0.04% at 1359.50 pence
dplewis1
09/1/2025
11:25
#892. More bought in R&D which will go on the Balance Sheet and not impact profits. Remember, it will have to be amortised at some date.
GSK needs to have much more home grown R&D from its extensive in-house facilities.

alphorn
09/1/2025
11:18
Dividends reached my AJ Bell accounts this morning .... ;0)
tradermichael
08/1/2025
15:10
*GSK NEARS $1BN DEAL FOR BIOTECH IDRX DEVELOPING DRUG FOR RARE TUMOUR- FT
dplewis1
08/1/2025
11:21
However, the available evidence was insufficient to establish a causal relationship, the FDA said.

(The risks flagged in the prescribing information of GSK's Arexvy and Pfizer's Abrysvo were not the regulator's strictest "boxed" warnings.)

tradermichael
08/1/2025
10:41
Not going to help sentiment sadly..

"GSK, Pfizer RSV shots to get warning of rare neurological disorder"

The U.S. FDA is ordering that respiratory syncytial virus (RSV) vaccines marketed by GSK (NYSE:GSK) and Pfizer (NYSE:PFE) contain a warning on labeling of the risk of developing the rare neurological disorder Guillain-Barré syndrome ("GBS").
The FDA Safety Communication impacts GSK's Arexvy and Pfizer's Abrysvo.

The agency said it made the decision based on post-marketing observational studies of the two shots, as well as adverse event reports.

Analyses of all GBS cases based on claims data suggest an increased risk of the disease during the 42 days following vaccination, with an estimated nine excess cases of GBS per million doses of Abrysvo, and seven excess cases per million doses of Arexvy, according to the FDA.

With GBS, an individual's immune system wrongly attacks part of their peripheral nervous system, which carries signals from the brain and spinal cord to the rest of the body.

geckotheglorious
08/1/2025
10:37
15p/share dividend pays out tomorrow ..... ;0)
tradermichael
07/1/2025
15:31
Well at this embarrassingly low share price I've sold a few other holdings and added to my GSK today.
mister md
07/1/2025
10:32
More good news for GSK

"GSK ADC gets FDA breakthrough therapy designation"

GSK's B7-H3-targeted antibody-drug conjugate, GSK'227, receives US FDA Breakthrough Therapy Designation in late-line relapsed or refractory osteosarcoma


And yet sentiment in stock seems unmovable.

Tempted to buy myself.

geckotheglorious
06/1/2025
21:23
Good time to short GSK? I'm thinking so.
criticalthinker1
06/1/2025
18:26
Mega volume today post 2.30pm let's hope a US bidder is moving in
dplewis1
06/1/2025
16:07
I suppose you can't compare GSK to Nvidia though or any of the Mag-7 stocks that drove most of the US gains. Take a company like Disney - also flat over 10 years or so.
But the innovative companies do mostly seem to originate over there, have better access to funding etc.

mister md
06/1/2025
09:01
Monty that's why I prefer BHP over RIOBHP delisted in London and moved to Australia, so now I can buy BHP with no stamp duty. Hopefully GSK will move to the US
gateside
06/1/2025
08:35
Problem I have with FTSE 100, stamp duty is a rip off, valuations are dire on the ftse. GSK shareprice below what it was 35 years ago, ok dividends.Nvidia up 170% in 2024, predicted another 50% this year. No wonder companies want to leave London market and go to US for a better rating. UK gilts and US tech for me.
montyhedge
Chat Pages: 1368  1367  1366  1365  1364  1363  1362  1361  1360  1359  1358  1357  Older

Your Recent History

Delayed Upgrade Clock